Literature DB >> 15209630

Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.

Harikleia Kalekou1, Dimosthenis Miliaras.   

Abstract

BACKGROUND: The purpose of the present study was to investigate microvessel density (MVD), and the expression of CD44 adhesion molecule, p53 protein and c-erbB2 in gallbladder carcinoma, and their relation to histological grade and tumor invasiveness.
METHODS: Immunohistochemical staining with antibodies against factor VIIIRAg, CD44 standard form (CD44s), p53 protein and c-erbB2 was performed on paraffin sections from 33 cases of gallbladder carcinoma.
RESULTS: Significant increase of MVD with increasing depth of invasion (P < 0.02) was observed. No association of MVD with histological differentiation, CD44s, p53 and c-erbB2 protein expression was found. The expression of p53 protein was significantly higher in deeply invasive tumors (P = 0.028) and in moderately and poorly differentiated carcinomas (P < 0.05). The CD44s expression was higher in well-differentiated carcinomas (P < 0.05). c-erbB2 expression was found in 30.4% of tumors studied, but did not relate to any other parameters.
CONCLUSION: Microvessel density and p53 protein expression increase progressively with increasing tumor invasiveness in gallbladder carcinomas. Microvessel density, p53 protein, CD44s, and perhaps c-erbB2 expression may be implicated in gallbladder carcinoma evolution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209630     DOI: 10.1111/j.1440-1746.2004.03357.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.

Authors:  Kiran Lata Sharma; Anu Yadav; Annapurna Gupta; Sonam Tulsayan; Vijay Kumar; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2013-11-05

2.  A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.

Authors:  Hiroshi Yoshida; Kazuaki Shimada; Tomoo Kosuge; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-01-13       Impact factor: 4.064

3.  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.

Authors:  Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima; Sei Shu; Nobuyuki Ishikura; Shunichi Ariizumi; Masakazu Yamamoto; Kunihiko Kurosaki; Junichi Shoda
Journal:  J Gastroenterol       Date:  2014-08-12       Impact factor: 7.527

4.  Expression of HER2 and bradykinin B₁ receptors in precursor lesions of gallbladder carcinoma.

Authors:  Cesar Toledo; Carola E Matus; Ximena Barraza; Pamela Arroyo; Pamela Ehrenfeld; Carlos D Figueroa; Kanti D Bhoola; Maeva Del Pozo; Maria T Poblete
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

5.  HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.

Authors:  Toru Kawamoto; Savitri Krishnamurthy; Emily Tarco; Smita Trivedi; Ignacio I Wistuba; Donghui Li; Ivan Roa; Juan C Roa; Melanie B Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-11

6.  Investigation of targetable predictive and prognostic markers in gallbladder carcinoma.

Authors:  Azfar Neyaz; Nuzhat Husain; Sameer Gupta; Swati Kumari; Aditi Arora; Namrata Puneet Awasthi; Kiran Preet Malhotra; Sanjeev Misra
Journal:  J Gastrointest Oncol       Date:  2018-02

7.  Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.

Authors:  Amita Chaube; Mallika Tewari; R S Garbyal; Usha Singh; Hari S Shukla
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

Review 8.  HER2-targeted therapies - a role beyond breast cancer.

Authors:  Do-Youn Oh; Yung-Jue Bang
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

9.  p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer.

Authors:  Mila Ghosh; Puja Sakhuja; Shivendra Singh; Anil K Agarwal
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

10.  Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.

Authors:  Takeshi Miwa; Takuya Nagata; Hirofumi Kojima; Shinichi Sekine; Tomoyuki Okumura
Journal:  Int J Oncol       Date:  2017-07-03       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.